Of note, the injection of an adeno-associated virus-CYP46A1 vector brought CYP46A1 and 24-OHC content back to control levels and the cognitive deficits were remedied, whereas tau hyperphosphorylation and gliosis were unaffected. This evidence concerns the gene MAPT and Cognitive impairment.